Stockreport

FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]

FibroBiologics, Inc.  (FBLG) 
PDF the Phase 1/2 clinical trial evaluating CYWC628 in diabetic foot ulcers (DFU) patients Preparing to submit Investigational New Drug applications for the treatment of p [Read more]